Nj State Employees Deferred Compensation Plan Zai Lab LTD Transaction History
Nj State Employees Deferred Compensation Plan
- $800 Million
- Q4 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Zai Lab LTD stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 11,300 shares of ZLAB stock, worth $314,253. This represents 0.04% of its overall portfolio holdings.
Number of Shares
11,300
Previous 11,300
-0.0%
Holding current value
$314,253
Previous $272,000
8.46%
% of portfolio
0.04%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding ZLAB
# of Institutions
125Shares Held
49.6MCall Options Held
223KPut Options Held
588K-
Janus Henderson Group PLC London, X08.76MShares$244 Million0.11% of portfolio
-
Wellington Management Group LLP Boston, MA8.44MShares$235 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA6.44MShares$179 Million0.02% of portfolio
-
Viking Global Investors LP1.95MShares$54.2 Million0.18% of portfolio
-
Bamco Inc New York, NY1.91MShares$53 Million0.13% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $2.72B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...